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We have previously isolated a new actinomycete strain from Tunisian soil called Streptomyces sp. US24, and have shown that
it produces two bioactive molecules including a Cyclo (L-Phe, L-Pro) diketopiperazine (DKP). To identify the structural genes
responsible for the synthesis of this DKP derivative, a PCR ampliﬁcation (696bp) was carried out using the Streptomyces sp. US24
genomic DNA as template and two degenerate oligonucleotides designed by analogy with genes encoding peptide synthetases
(NRPS). The detection of DKP derivative biosynthetic pathway of the Streptomyces sp. US24 strain was then achieved by gene
disruption via homologous recombination using a suicide vector derived from the conjugative plasmid pSET152 and containing
the PCR product. Chromatography analysis, biological tests and spectroscopic studies of supernatant cultures of the wild-type
Streptomyces sp. US24 strain and three mutants obtained by this gene targeting disruption approach showed that the ampliﬁed
DNA fragment is required for Cyclo (L-Phe, L-Pro) biosynthesis in Streptomyces sp. US24 strain. This DKP derivative seems to
be produced either directly via a nonribosomal pathway or as a side product in the course of nonribosomal synthesis of a longer
peptide.
Copyright © 2007 Samiha Sioud et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Peptides are involved in a wide number of physiologic and
biochemical processes, including metabolism, pain, repro-
duction, and the immune response. While many naturally
occurring peptides are linear compounds, nature also pro-
vides us with a wide variety of monocyclic and polycyclic
peptides and proteins of all diﬀerent shapes and sizes [1].
Among them, diketopiperazines (DKP), cyclic dipeptides,
are the smallest head-to-tail cyclic peptides and form a very
attractive family because of their many potential uses. In
fact, useful biological properties have been demonstrated
for some of them such as antibacterial, fungicidal, herbici-
dal, antiviral, immunosuppressor, and antitumour activities
[2, 3]. Although the number of newly isolated naturally oc-
curring DKPs has increased during the last few years, the
biosynthetic pathways of these molecules remain largely un-
explored. Generally, DKP derivatives seem to be produced by
three diﬀerent ways. The ﬁrst one is nonribosomal pathway
andproductformationtakesplaceunderthecatalyticcontrol
of a large multimodular enzyme complex, termed NRP syn-
thetase (NRPS). Molecular characterization of NRPS genes
has revealed a modular organisation [4] in which each mod-
ule within this biosynthetic assembly line is responsible for
the recognition, activation, and incorporation of a certain
amino acid into the nascent peptide product. Such catalytic
unit (module) is composed of functionally speciﬁc and in-
dependent domains, each of them responsible for catalyz-
ing one single reaction. Much of the attention in the ﬁeld
of NRPSs is attracted by the potential to obtain new peptide
products with novel biological activities by directed engi-
neeringofthebiosyntheticgenes.Infact,themodularorgan-
isationofNRPSslendsitselftobiocombinatorialapproaches,
such as domain and module swapping, as well as fusion and
truncation of existing catalytic units [5].
DKP derivatives can be also obtained as a side product in
the course of nonribosomal synthesis. It is the case of
the Cyclo (Phe-Pro) formation during the nonribosomal
synthesis of tyrocidine A and gramicidin S in certain strains
of Bacillus brevis. Tyrocidine A, (Phe-Pro-Phe-DPhe-Asn-
Gln-Tyr-Val-Orn-Leu-)cyc, is produced at the onset of the
stationary phase of growth of Bacillus brevis ATCC 81852 Journal of Biomedicine and Biotechnology
strain via a nonribosomal pathway and possesses antibiotic
activities against several gram positive bacteria [6]. Grami-
cidin S, a cyclic decapeptide consisting of two identical pen-
tapeptides(Phe-Pro-Val-Orn-Leu)2,ispr oduc edviaanonri-
bosomal pathway by Bacillus brevis ATCC 9999 and presents
antibacterial activities [7].
The third DKP biosynthesis way has been described from
Streptomyces noursei. However, very little is known about the
DKP derivatives from Streptomyces species and their biosyn-
thetic pathways. The only isolated and studied DKP biosyn-
thetic gene cluster from this bacterium genus is that of al-
bonoursin of the Streptomyces noursei [8]. It has been re-
ported by these authors that the biosynthesis of the al-
bonoursin diketopiperazine is independent of nonribosomal
peptide synthetases.
We have previously reported the isolation from Tunisian
soilofanewactinomycetestraincalledStreptomycessp.US24
producing divers biological activities, the puriﬁcation, and
the structure elucidation of two active molecules from this
bacterium [9, 10]. The ﬁrst one is the 3-indolethanol and the
secondactivemoleculeisaDKPderivative,theCyclo(L-Phe,
L-Pro) diketopiperazine. The aim of this work was to detect
the biosynthetic pathway of this DKP derivative. Our strat-
egy is based on gene disruption approach by homologous re-
combination via a suicide vector derived from pSET152 [11]
containing a 696bp DNA fragment ampliﬁed by PCR using
the Streptomyces sp. US24 genomic DNA as a template. The
detection of the biosynthetic pathway of the Cyclo (L-Phe,
L-Pro) diketopiperazine (DKP) derivative from the Strepto-
myces sp. US24 strain will permit the study and the compre-
hensionofthenaturalbiosynthesisofdiketopiperazinesfrom
Streptomyces genus and consequently the production of hy-
brid DKP molecules having interesting biological and phar-
macological activities.
2. MATERIALS AND METHODS
2.1. Bacterialstrains,plasmids,andprimers
Bacterial strains, plasmids, and primers used in this work are
listed in Table 1.
2.2. Mediaandcultureconditions
E. coli strains were grown in Luria broth (LB) medium.
Ampicillin (50μgmL−1), apramycin (50μgmL−1), chloram-
phenicol (25μgmL−1), nalidixic acid and kanamycin
(50μgmL−1) were added to growth media when required
and 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
(40μgmL−1) when appropriate [12]. Transformation of
E. coli DH5α with pGEM-T derivatives was carried out
according to the manufacture’s instructions (Promega,
Madison, USA ).
Streptomyces s p .U S 2 4s t r a i nw a sg r o w ni nT ry p t o n es o y a
broth medium (TSB: 30g tryptic soy broth plus 5g Yeast ex-
tract per 1000mL distilled water) for the preparation of ge-
nomicDNA[13]andonR2YE[14]platesforthepreparation
of spore stocks. TSB supplemented with 30μgo fa p r a m y c i n
mL−1 was used to grow exconjugants.
AS1 medium [18]: 1g Yeast extract, 5g Soluble starch,
0.2g L-alanine, 0.2g L-arginine, 0.5g L-asparagine, 2.5g
NaCl, 10 g Na2SO4, and 20g agar, pH adjusted at 7.5
with KOH, was used for conjugation experiments, and cul-
tureswere grown at 37◦C.
For biological activity production, Streptomyces sp. US24
strain and the corresponding exconjugants were grown in
TSB medium, supplemented at 1% (w/v) with starch and
0.1% (v/v) of a trace element solution: (0.4gL−1 ZnCl2;
2gL −1 FeSO4 · 7H2O; 0.065gL−1 H3BO3, and 0.135gL−1
MoNa2O4 ·2H2O).
For antibacterial activities determination, indicator mi
croorganism Micrococcus luteus LB14110 was grown
overnight in LB medium at 30◦C, then diluted 1:100 in LB
medium and incubated for 5 hours under constant agitation
of 200 rpm at the appropriate temperature.
2.3. Intergenericconjugation
Intergeneric conjugation between E. coli and Streptomyces
sp. US24 strainwas performed as described previously by
F l e t te ta l .[ 19], with some modiﬁcations: E. coli ET12567
(pUZ8002/pSET152) was grown to an absorbance of 0.4–0.6
at 600nm. The cells were pelleted by centrifugation, washed
twice in an equalvolume of LB, pelleted again, and ﬁnally re-
s u s p e n d e di n1 / 1 0v o l u m eo fL B .A l i q u o t so fStreptomyces sp.
US24 spore suspension store at −20◦C were used as recipi-
ents. Spores (eq108) were washed in 2x Yeast extract Tryp-
tonemedium [20], resuspended in 500μL of 2x Yeast extract
Tryptone medium, and incubated at 50◦Cf o r1 0m i n u t e s
to induce germination. Donor cells (500μL approximately
108 cells) were added to the treated spores, the mixture was
pelleted by centrifugation, and ﬁnally the pellet was resus-
pended in the residual liquid and the undiluted mixture was
plated on AS1 plates containing 10mmol MgCl2 and in-
cubated at 37◦C for 18 hours. The plates were then over-
laid each with 1mL of water containing 500μg of nalidixic
acid and 1mg of apramycin, incubated further for 5 days
at 37◦C. The exconjugants were then counted. Cultures pre-
pared from some arbitrary chosen clones were used for fur-
therstudies.
2.4. DNAisolationandmanipulation
Total DNA preparation was carried out from Streptomyces
strains (sp. US24 and the corresponding exconjugants) ac-
cordingtoHopwoodetal.[21].Small-scaleplasmidprepara-
tions from E. coli were performed as described by Sambrook
et al. [12].
Digestion with restriction endonucleases, separation of
DNA fragments by agarose gel electrophoresis, dephospho-
rylation with alkaline calf intestinal phosphatase, ligation of
DNA fragments and transformation were done according to
Sambrook et al. [12]f o rE. coli and Hopwood et al. [21]f o r
Streptomyces.
For Southern blot manipulations [22], DNA was trans-
ferred to Hybond N membranes (Amersham, Buckingham
shire, UK). The hybridization conditions and subsequentSamiha Sioud et al. 3
Table 1: Bacterial strains, plasmids, and primers used in this work.
Strain, plasmid, and primer Description Reference or Source
Strains
Streptomyces sp. US24
Cyclo (L-Phe, L-Pro) diketopiperazine producer, used in this work as the
source of chromosomal DNA to amplify the 696pb DNA fragment as
recipient for intergeneric conjugation and targeted gene disruption
[10]
E. coli DH5α General cloning host (F−φ80 dlacZΔM15Δ(lacZYA-argF) U169 endA1
recA1hsdR17(r
−
k ,m +
k) deoR thi-1 susE 44 λ
− gyrA96 relA1)
[15]
E.coli ET12567 methylation-defective (dam-13:: Tn9 dcm-6 hsdM Cmr) used for
conjugation between E. coli and Streptomyces
[16]
Micrococcus luteus Indicator microorganism LB 14110
Plasmids
pSET152 Integrative vector carrying ϕC31 integrase gene and ϕC31 attP site, oriT
and an apramycin resistance gene for selection in Streptomyces and E. coli
[11]
pUZ8002 RK2 derivative with a mutation in oriT. [17]
pGEM-T Easy vector TA cloning vector AmpR (PCR products cloning) Promega
pSS1
Derivative of pGEM-T Easy vector carrying a 696pb DNA fragment
involved in the biosynthetic pathway of Cyclo (L-Phe, L-Pro) DKP of the
US24 strain
This work
pSS2 Suicide vector derivative of the pSET152 This work
pSS3 pSS2 carrying the EcoRI DNA fragment insert from pSS1 This work
Primers
[P1/P2] Primers used for the ampliﬁcation of the 696pb DNA fragment This work
P1 5’ATCTACAC(G/C)AGCGGGACGAC(G/C)GGC3’
P2 5’(G/C)AGGTCGCC(G/C)GTGCGGTACAT3’
detection were in accordance with the manufacturer’s in-
structions. 32P-labeled probes were prepared using the ran-
dom prime labelling system (Amersham).
PCR ampliﬁcation of the 696bp DNA fragment, in-
volved in the biosynthesis pathway of Cyclo (L-Phe, L-
Pro) DKP of the Streptomyces sp. US24 strain, was per-
formed using two degenerate primers (P1, P2) as described
in Table 1. Approximately 150ng genomic DNA was used
as template with 100pmol of each primer per 50μLr e a c -
tion volume. To improve the denaturation of the DNA, 5%
(v/v) DMSO was added to the reaction mixture. Ampliﬁ-
cation was performed in a Gene Amp PCR System 2700
(Applied Biosystems, Foster city, USA) using 1U Pfu DNA
polymerase (Stratagene, Amsterdam, The Netherlands) and
the recommended buﬀer system according to the follow-
ing ampliﬁcation proﬁle: 94◦C( 5m i n u t e s )f o l l o w e db y
45 cycles of denaturation at 94◦C (30 seconds), anneal-
ing at 60◦C (60 seconds) and extension at 72◦C( 9 0s e c -
onds). The PCR products were analysed by agarose gel elec-
trophoresis and fragment of the expected size was puriﬁed
then cloned into pGEM-T Easy vector yielding pSS1 plas-
mid.
Nucleotide sequences were determined on both strands
using the dideoxy chain-termination method [23]. Reactions
were performed with a Thermo sequenase cycle sequencing
kit (Amersham) and speciﬁc primers. Homology search was
performed using Blast Search algorithm [24].
2.5. Extraction,puriﬁcationofactivecompounds,
biologicalassayofantimicrobialactivities,LC/MS
andLC/MS/MSanalysis
For the puriﬁcation of the active molecules from the Strepto-
myces sp. US24 strain and three corresponding mutants (ob-
tainedaftertransferofthepSS3“seeTable 1”intotheStrepto-
myces sp. US24 strain), spores at 107 mL−1 wereused toinoc-
ulate500mLErlenmeyerﬂaskswithfourindents,containing
100mL TSB medium supplemented at 1% (w/v) with starch
and 0.1% (v/v) of a trace element solution [9]. After incuba-
tion at 37◦C for 24 hours in an orbital incubator with shak-
ing at 250rpm, this preculture was used to inoculate (5%
v/v) a total volume of 1L culture medium having the same
composition of the preculture. After three days incubation at
37◦C in an orbital incubator with shaking at 250rpm, each
culture broth was ﬁltered to separate mycelium and super-
natant. The supernatant was extracted twice with an equal
volume of ethyl acetate and then evaporated on a Rotavapor
(Laborata 4000). The crude extract, approximately 100mg
for each culture, was dissolved in 500μL dichloromethane-
methanol 1:1 and fractioned by HPLC. This analysis was
performed with an analytical column (C18 column 7μm,
4.6mm inner diameter 25cm length). The elution was at
aﬂ o wr a t eo f1m Lm i n −1 with a gradient of two solutions
A (water, 0.1% formic acid) and B (acetonitrile, 0.1% formic
acid). After injection of the sample, the column was eluted4 Journal of Biomedicine and Biotechnology
with a linear gradient from 100% buﬀer A to 50% buﬀer A
and 50% buﬀer B over the ﬁrst 40 minutes, followed by a
linear gradient to 100% buﬀe rBf r o m4 0t o6 0m i n u t e s ,a n d
thenasteadyﬂowof100%buﬀerAthrough10minutes[10].
Elution was monitored using a UV detector at 220nm.
LC/MS and LC/MS/MS analyses were performed us-
ing an LC/MSD Trap XCT–Electrospray (Agilent Technolo-
gies), operatedin positive ionisation mode, equipped with an
HPLC Agilent 100 DAD detector (C18 column Zorbax 300
2.1 × 150mm). After injection of 5μL of the corresponding
sample, the column was eluted with a linear gradient 95%
buﬀer A (water, 0.1% formic acid) and 5% buﬀer B (acetoni-
trile, 0.1% formic acid) through 2 minutes, followed by a lin-
ear gradient to 80% buﬀer B and then a steady ﬂow of 20%
buﬀer A, 80% buﬀer B through 3 minutes. The elution was
at a ﬂow rate of 250μLm i n −1.
For biological assay of antimicrobial activity, a paper disk
was impregnated with 80μL of the corresponding sample,
andthenlaidonthesurfaceofanagarplatescontaining3mL
of top agar inseeded by 40μL of a 5-hour-old culture of M.
luteus LB 14110. After 2 hours at 4◦C, plates were incubated
at 30◦C for overnight and then examined for evidence of an-
timicrobialactivitiesrepresentedbyagrowthinhibitionzone
of the indicator micro-organism around the paper disk.
3. RESULTS AND DISCUSSION
3.1. PCRampliﬁcationofaStreptomycessp.US24DNA
fragmentpotentiallyinvolvedintheCyclo(L-Phe,
L-Pro)DKPderivativebiosynthesis
Although the biosynthetic pathways of DKP derivatives re-
main largely unexplored, in bacteria and fungi these ac-
tive molecules generally seem to be produced by nonriboso-
mal pathways (NRPS: nonribosomal peptide synthetases). In
analogytotype-Ipolyketidesynthases(PKSs),NRPSsexhibit
a modular architecture and a module can be further subdi-
vided into diﬀerent domains, each responsible for a certain
biochemical reaction. The adenylation domain (A-domain)
controls the entry of the substrates into the peptide as it rec-
ognizes and adenylates its cognate substrate. The thiolation
domain (T-domain) is referred to as peptidyl carrier protein
(PCP), from where it is condensed with the aminoacyl or
peptidyl moieties at the neighboring modules. The latter re-
action is catalyzed by the condensation domain (C-domain).
These three domains, C, A, and T, constitute a minimal elon-
gation module, the basic repetitive unit of multimodular
NRPSs. Accordingly, the ﬁrst module of an NRPS complex
lacks a C-domain, whereas the last module usually contains
also a termination domain (Te-domain) to release the prod-
uct. This modular architecture oﬀers a real potentiality to
constructnewhybridpeptideswithnovelbiologicalactivities
by directed engineering of the biosynthetic genes. The aim of
this work was to detect the biosynthetic pathway of the Cy-
clo (L-Phe, L-Pro) active molecule produced by Streptomyces
sp. US24. For that purpose, two degenerate oligonucleotides
(P1 and P2) were prepared, according to the typical Strepto-
myces codonusage,basedontheaminoacidsequencesalign-
ment of two synthetases 1 of the Tyrocidine A and Gram-
icidin S, respectively. For these two decapeptides, Phe and
Pro are the residues number one and two, respectively. Three
genes (tycA, tycB,a n dtycC) coding for three proteins of 124,
405, and 724 kDa, respectively, are involved in the biosyn-
thesis of the Tyrocidine A. TycA (synthetase 1) comprises
only one module corresponding to the phenylalanine ac-
tivase (phenylalanine activing domain) and racemase [25].
In the biosynthesis of the Gramicidin S, three open reading
frames organised in one transcriptional unit were identiﬁed
and the corresponding genes are called grsT, grsA,a n dgrsB.
The GrsA (Gramicidin S synthetase 1) is an enzyme with a
molecular weight of 126.6kDa which activates and racemize
the amino acid phenylalanine as the ﬁrst step in nonriboso-
mal biosynthesis of the peptide antibiotic gramicidin S [7].
Comparison of the amino acid sequences of GrsA and TycA
revealed an extensive degree of homology over 56%. If simi-
lar amino acids are also considered, the degree of homology
increases to over 70% [26]. This amino acid comparison lets
us ﬁnd two conserved regions IYTSGTTG and MYRTGDL
belonging to the adenylation domains of the two synthetases
1GrsAandTycA.Thesetwoconservedregionsarepartofthe
known highly conserved core motifs of the adenylation do-
mainsofallknownNRPSs.Accordingly,twodegeneratePCR
primers forward P1 and reverse P2 were designed (Table 1)
and used in a PCR reaction with the Streptomyces sp. US24
genomic DNA as template. A PCR product with an expected
size of approximately 700bp was obtained. After puriﬁca-
tion, this DNA fragment was cloned in the pGEM-T Easy
vector, yielding the pSS1 plasmid. The insert of four ran-
domly chosen clones was sequenced. All obtained nucleotide
sequencesareidenticalandshowedatypicalStreptomycesGC
content (about 76%). This identity can be explained by the
high-stringency PCR conditions and the low degree of de-
generationofthetwousedprimers.Frameanalysisofthenu-
cleotidesequence(696bp,accessionno.AM282973)revealed
the presence of a unique internal open reading frame. The
alignment of the corresponding amino acid sequence (aa)
withallavailableproteinsequencesusing theGappedBLAST
and PSI-BLAST program [24] showed as expected impor-
tant aa identities with diﬀerent NRPS adenylation domains.
This identity reaches 50% and 48% with the adenylation do-
mains of the pristinamycin I (PI) synthetase 2, and actino-
mycin (ACM) synthetase III, respectively (Figure 1). These
two adenylation domains activate the two amino acids L-
threonineandL-aminobutyricofthePIproducedbyStrepto-
myces pristinaespiralis, and the three amino acids proline, N-
methylglycine and N-methyl-L-valine of the ACM produced
by Streptomyces chrysomallus, respectively [27, 28].
3.2. Constructionofsuicidevectorderived
frompSET152
Streptomyces sp. US24 was refractory to classical polyethy-
lene glycol transformation and electroporation procedures
(data not shown). Therefore, we decided to use another
approach involving intergeneric conjugation from Ec o l i
into Streptomycetes [29]. As part of this approach, we have
constructed a conjugative suicide vector derived from the
integrative conjugative pSET152 vector. This plasmid wasSamiha Sioud et al. 5
 US 24  1 -------------------------------------------------IYTSGTTGE PK
 SnbC  1603 VLLTDRATDTAHECRSWAGDADVLVVDE L P TGGEPLPVVPAHPHQLAYVMYTSGSTGNPK
AcmC 3096 LLITD HTTDLDTTTTQFN-PADTPHDGEDP ----G N PNHTTHPDDAAYIMYTSGSTGR PK
Consensus vlltdr td w ad e p p hp ayv mYTSGs TG PK
US 24  12 PSPYATATWP PWP PTAAS PAVCATGCCLHSPVAFDAATFEV W GPLLTGGCVVVAPSRPLD
SnbC 1663 GVAITHGDVAALAADTCWRTGNQQRVLLHSPY SFDT SQYELWVPLLSGGTVVVAPPGDLD
AcmC 3151 GVIATHRNI TALALDPRFDPTAHRRVLLHSPTAFDASTYEIW VPLLNGNTVVLAPTGDLD
Consensus gv tha v ala d w rvlLHSP aFDastyEv W vPLLtGgtV VvAPsgdLD
US 24  72 S ALLRRLVRDTGLSALWLTAGLFR LLAQDAPDCFTGLRQV W TGGDVVPAAAVRRVLAACP
SnbC 1723 TRAL ERA I VDGGVTGM WLTSGLFNLLAEESPHCFTGVREV WTGGDVVSPAAVARVLAAS P
AcmC 3211 VHTYHRV I TDQQ ITAL W LTSWVFNLLT EQSPET FTRVRQIWTGGEAVSGATVTRLQQACP
Consensus sr lrRli D gltal W L TsglFnLLaedsPdcF TgvR qv W T G G dv VsaAa V RvlaAcP
 US 24  132 GLTVVDGYGPTETTTFATSSAL TDAATVPDTVPIGHPLDDMRVHVLDGRLRPVPPGCPGE
 SnbC  1783 S TMVADGYGPTETTTFATHHFMRAPWQQETTVPIGT PLDNTTCHVLDDRLRPVPPGVTGE
AcmC 3271 DTTVVDGYGPTETTTFATHHPVPTPYTGSAVVPIGRPMATMHTYVLDDS LQPVAPGVTGE
Consensus ttVvDGYGPTETTTFAThh l pwt tVPIGhPl d mr hVLDdrLrPVpPGv tGE
  US 24  192 LYLAGEGVARGYLGRPGDTAARFLADPAGPPGS RMYRTGDL -------------------
SnbC 1843 L YIG GSGLARGYLNRPE LTAERFVADPYAP- GGRMYRTGDLVR LRRDGVL T F LGRADHQV
AcmC 3331 LYLAGSGLARGYLDRPALTAERFVANPYAAPGERMYRTGDLARWN P DDHL E YAGRADHQV
Consensus L YlaGsGlA R G YL RPglT AeRFvAdPyapp G R MYRTGDL rd l f g r a d h q v
Figure 1: Alignment of amino acid sequences of the 696bp DNA fragment of Streptomyces sp. US24 with pristinamycin I synthase 2 (SnbC)
of Streptomycespristinaespiralis,andactinomycinsynthaseIII(AcmC)of Streptomyces chrysomallus.Consensussequence(cons)corresponds
to the amino acids conserved. The two conserved regions used to design the two degenerate oligonucleotides (P1 and P2) are highlighted.
chosen because it is successfully transferred from E. coli
ET12567/pUZ8002 into Streptomyces sp. US24 strain by
intergeneric conjugation, and corresponding directed-site
speciﬁc recombination has been characterised and anal-
ysed (data not shown). To obtain a nonintegrative form of
pSET152, the plasmid was partially digested by the restric-
tion endonuclease HindIII and a resulting 4.8kb DNA frag-
ment was puriﬁed, in which, a part of the integrase encod-
ing gene of the pSET152 has been deleted. After ligation
and transformation of E. coli cells, recombinant clones were
obtained harbouring the desired pSET152 suicide derivative
vector called pSS2.
3.3. Integrationbyhomologousrecombination
The 696bp DNA fragment was puriﬁed from pSS1 after its
digestion by EcoRI and then cloned into pSS2 digested by
the same enzyme giving pSS3. This plasmid can be inte-
grated into the chromosome of the Streptomyces sp. US24
strain only via homologous recombination. After transfer of
the pSS3 plasmid into the E. coli ET12567 (pUZ8002) strain,
we have realized an intergeneric conjugation between E. coli
ET12567 (pUZ8002/pSS3) and Streptomyces sp. US24 strain.
Streptomyces sp. US24 AprR (apramycin resistant) exconju-
gants were obtained witha frequencyof 10−9.Th i sf r eq u e n c y
is a thousand times less comparing to the transconjugation
eﬃciency (10−6) (data not shown) of the native pSET152
which integrates into the Streptomyces sp. US24 chromo-
some by site-speciﬁc recombination between its attP and
the chromosomal attB site. This observation lies well with
the previously reported ﬁnding illustrating that integration
viahomologousrecombination usuallyoccurs102–103 times
less frequently than attB/P. mediated integration. All ob-
tained exconjugants grew well and there are no morpho-
logical diﬀerences comparing to the wild-type strain. Ho-
mologous integration of pSS3 was veriﬁed by Southern hy-
bridisation using the 696bp DNA fragment and the pSS2 as
probes(Figure 2(a)).Whenthe696bpDNAfragmentisused
as probe, BamHI digested chromosomal DNA of the wild-
type strain Streptomyces sp. US24 hybridized with only one
6kb DNA fragment, whereas with the BamHI digested chro-
mosomal DNA of one analysed exconjugant, two hybridiza-
tion signals of about 4 and 10kb were obtained. Using as
probe the pSS2 plasmid linearized by BamHI, there is sin-
gle BamHI site within the multiple cloning site of this vec-
tor, one hybridization signal of about 10kb was obtained for
the chromosomal DNA of the analysed mutant strain and
no signal for the wild type. Knowing that the 696bp ampli-
ﬁed DNA fragment has no BamHI site, obtained hybridiza-
tion results are in concordance with a homologous recom-
bination of the 696bp DNA fragment via a single crossover
into the chromosome of the Streptomyces sp. US24 strain
(Figure 2(b)).6 Journal of Biomedicine and Biotechnology
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Figure 2: (a) Southern blot analysis conﬁrming insertion of pSS3 plasmid into the Streptomyces sp. US24 chromosome via homologous
recombination. Blots were probed with the 696bp DNA fragment (right panel) or the whole linearized pSS2 (left panel). Lanes 4 and 8, 1kb
ladder used as molecular marker, lanes 2 and 6, wild-type genomic DNA cut withBamHI, lanes 1 and 5, apramycin resistant (AprR)e x c o n j u -
gant mutant genomic DNA cut with BamHI, and lanes 3 and 7, the used probes linearized pSS2 and 696bp DNA fragment, respectively. (b)
Schematic representation of the integration of plasmid pSS3 in the chromosome of Streptomyces sp. US24 by homologous recombination.
The resident copy of the 696bp locus involved in the biosynthetic pathway of Cyclo (L-Phe, L-Pro) DKP of the US24 strain (shaded boxes)
present in the chromosome of Streptomyces sp. US24 is shown. del int: deletion of a part of the integrase-encoding gene by partial digestion
HindIII; aac(3)IV: apramycin resistance gene; B: restriction site for BamHI; E: restriction site for EcoRI.
3.4. The696bpampliﬁedDNAfragmentrequired
fortheCyclo(L-Phe,L-Pro)DKPderivative
biosynthesis
TodeterminewhethertheampliﬁedDNAfragmentof696bp
is really involved in Cyclo (L-Phe, L-Pro) biosynthesis, ap-
proximately 100mg of crude extract for each culture, ob-
tained after ethyl acetate extraction from 1L supernatant
culture of the Streptomyces sp. US24 strain and of three
diﬀerent AprR exconjugant mutants (MI, MII, and MIII),
was dissolved in 500μL dichloromethane-methanol 1:1 and
fractioned with an analytical HPLC column. For the three
analysed exconjugants, obtained chromatograms are identi-
cal and present global proﬁles quite similar to that of the
wild type. Six fractions were collected separately between
0 and 50 minutes both for the wild type and one excon-
jugant (Figure 3). F1 to F6: (F1 “0–13 minutes”; F2 “13–
21 minutes”; F3 “21–26 minutes”; F4 “26–31 minutes”; F5
“31–40 minutes,” and F6 “40–50 minutes”). These fractions
were concentrated by Rotavapor and then tested for their an-
tibacterial activities against M. luteus. For the Streptomyces
sp. US24 strain, an inhibitory activity was detected for the
two fractions F3 and F5. However, concerning the three ex-
conjugant mutants, only the F5 fraction was active and the
corresponding diameter of inhibition zone was comparable
to that of F5 fraction of the Streptomyces sp. US24 strain
(Table 2). These microbiological results strongly suggest the
presence of the Cyclo (L-Phe, L-Pro) active molecule in the
crudeextract(fractionF3)onlyfortheStreptomycessp.US24
wild-type strain. It should be noted that according to our
previous work [10], the active molecule Cyclo (L-Phe, L-
Pro) was puriﬁed from the culture supernatant of Strep-
tomyces sp. US24 strain with a retention time of 25 min-
utes using the same HPLC conditions used in the present
work. This retention time was included in the time interval
of the fraction F3 (21–26 minutes). The biological activity
observed in the fraction F5 for the four crude extracts (that
of the wild type and those of the three mutants) is due to
the 3-indolethanol molecule. In fact, Mehdi-Ben Ameur et
al. [10] have extracted puriﬁed and characterized two activeSamiha Sioud et al. 7
Table 2: Antibacterial activities against M. luteus of the crude ex-
tracts HPLC fractions of the wild-type Streptomyces sp. US24 and
the three studied exconjugant mutant strains.
Diameter (mm) of inhibition zones
Strain F1 F2 F3 F4 F5 F6
Streptomyces
sp. US24 00 1 4 0 1 0 0
Exconjugant
mutants
M I 0000 1 0 0
M I I 0000 1 0 0
MIII 0 0 0 0 10 0
molecules from the supernatant culture of the Streptomyces
sp. US24 strain: the Cyclo (L-Phe, L-Pro) “M+ = 244”,
and the 3-indolethanol “M+ = 161”. These results are in
perfect concordance with those obtained by the determina-
tion of the extracted ion chromatograms (EIC), after ace-
tonitrile removing of the four F3 fractions and LC/MS and
LC/MS/MS studies. Indeed, for the three exconjugant mu-
tants, we have obtained identical (EIC) which are completely
diﬀerent to that of the wild-type Streptomyces sp. US24. Only
this later presents two overlapping important peaks between
4.5 and 5.2 minutes (Figure 4(a)). LC/MS analysis of the dif-
ferent products of these two peaks reveals the presence of
an ion corresponding to [M+H]
+ = 244.8a t4 . 7m i n u t e s .
LC/MS/MS analysis of this ion gives three ion fragments at
m/z 216.8, m/z 119.9, and m/z 70.2 (Figure 4(b)). These ex-
pected fragments have been already obtained in EI/MS anal-
ysis during our previous works concerning the Cyclo(L-Phe,
L-Pro) of the Streptomyces sp. US24 strain (data not shown).
The ion fragments at m/z 120 and m/z 70 correspond to
the immonium ion of Phe and Pro, respectively. Otherwise,
LC/MS and LC/MS/MS analysis of the four active F5 frac-
tions showed the presence of an ion of [M+H]
+ = 162 at
7 minutes for the wild type as well as for the three mu-
tants (MI, MII, and MIII) crude extracts. Corresponding
ion fragments were identical for all the four F5 fractions
[M+H]
+ = 162 “m/z 118.7 and m/z 118.7”. These results
are in concordance with those obtained previously (data
not shown) concerning the active molecule 3-indolethanol:
“M+ = 161”.
Together, all these data (microbiological, chemical, and
spectroscopic studies) supported the presence of the active
molecule Cyclo (L-Phe, L-Pro) only in the crude extract of
the wild-type Streptomyces sp. US24, and the active molecule
3-indolethanol in all the four analysed crude extracts (that of
Streptomyces sp. US24and those ofMI,MII,andMIIIexcon-
jugantmutants).Consequently,theampliﬁedDNAfragment
of 696bp from the genomic DNA Streptomyces sp. US24
strain is proven to be involved in its Cyclo (L-Phe, L-Pro)
biosynthetic pathway.
However, to our knowledge for Streptomyces species, the
onlyisolatedandstudiedDKPbiosyntheticgeneclusterfrom
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Figure 3: HPLC chromatograms in semipreparative conditions of
thecrudeextractsof1Lsupernatantculturesofthewild-typeStrep-
tomyces sp. US24 strain (I) and one exconjugant mutant (II). Six
fractions were collected separately between 0 and 50 minutes both
forthewildtypeandoneexconjugant.F1toF6:(F1“0–13minutes,”
F2 “13–21 minutes,” F3 “21–26 minutes,” F4 “26–31 minutes,” F5
“31–40 minutes,” and F6 “40–50 minutes”).
this bacterium genus is that of albonoursin of the Strepto-
myces noursei [8]. It has been reported by these authors that
the biosynthesis of the albonoursin diketopiperazine is inde-
pendent of nonribosomal peptide synthetases. Contrarily, in
our case, the biosynthesis of the DKP derivative Cyclo (L-
Phe, L-Pro) by the Streptomyces US24 seems to be a nonri-
bosomal pathway. To this level of work, two hypotheses can
be proposed. The ﬁrst one is to consider the direct produc-
tion by the Streptomyces sp. US24 strain of the Cyclo (L-Phe,
L-Pro) via a nonribosomal pathway. The second hypothesis
is the obtaining of this active molecule as a side product in
the course of nonribosomal synthesis of a longer peptide by
the Streptomyces sp. US24. In fact, the Phe-Pro dipeptide can
be released from the NRPSs by a nonenzyme-catalysed reac-
tion to give the Cyclo (Phe-Pro). This is due to the high pro-
portion of cis conformation in the Phe-Pro dipeptide, which
is induced by N-alkylated amino acids such as Pro. Actu-
ally, our study is focused on the construction of a cosmid
library from the genomic DNA of the Streptomyces sp. US24
to identify the complete biosynthetic pathway of this DKP
derivative.8 Journal of Biomedicine and Biotechnology
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Figure 4: (a) Extracted ion chromatograms (EIC) of two fractions
F3: one of exconjugant mutant (I) and the second of the wild-
type Streptomyces sp. US24 strain (II). (b) LC/MS analysis (I) and
LC/MS/MS (II) fragments determination of the product of the peak
4.7 minutes (fraction F3 of the wild-type Streptomyces sp. US24
strain) corresponding to the ion [M+H]
+ = 244.8.
ACKNOWLEDGMENTS
This work was supported by the Tunisian government (Con-
tract Program CBS-LEMP) and the CMCU project (2006–
2008) N◦ 06/S 0901 “MELLOULI/AIGLE. The authors are
grateful to Dr. R. Mehdi-Ben Ameur and Dr. H. Chouayekh
for their generous help and useful conversations.
REFERENCES
[1] F. M. Brunel and A. F. Spatola, “Synthesis of diketopiperazines
with on-resin N-methylation and cyclative release,” Journal of
Peptide Research, vol. 63, no. 3, pp. 213–222, 2004.
[2] M. Chu, I. Truumees, M. L. Rothofsky, et al., “Inhibition of
c-fos proto-oncogene induction by Sch 52900 and Sch 52901,
novel diketopiperazines produced by Gliocladium sp,” Journal
of Antibiotics, vol. 48, no. 12, pp. 1440–1445, 1995.
[3] K.-H. Rhee, “Cyclic dipeptides exhibit synergistic, broad spec-
trum antimicrobial eﬀects and have anti-mutagenic proper-
ties,” International Journal of Antimicrobial Agents, vol. 24,
no. 5, pp. 423–427, 2004.
[4] S. Doekel and M. A. Marahiel, “Dipeptide formation on en-
gineered hybrid peptide synthetases,” Chemistry and Biology,
vol. 7, no. 6, pp. 373–384, 2000.
[5] S. Gruenewald, H. D. Mootz, P. Stehmeier, and T. Stachelhaus,
“In vivo production of artiﬁcial nonribosomal peptide prod-
ucts in the heterologous host Escherichia coli,” Applied and En-
vironmental Microbiology, vol. 70, no. 6, pp. 3282–3291, 2004.
[6] H.D.MootzandM.A.Marahiel,“Thetyrocidinebiosynthesis
operon of Bacillus brevis: complete nucleotide sequence and
biochemical characterization of functional internal adenyla-
tion domains,” J o u r n a lo fB a c t e r i o l o g y , vol. 179, no. 21, pp.
6843–6850, 1997.
[7] J. Kr¨ atzschmar, M. Krause, and M. A. Marahiel, “Gramicidin
S biosynthesis operon containing the structural genes grsA
and grsB has an open reading frame encoding a protein ho-
mologous to fatty acid thioesterases,” Journal of Bacteriology,
vol. 171, no. 10, pp. 5422–5429, 1989.
[8] S. Lautru, M. Gondry, R. Genet, and J.-L. Pernodet, “The
albonoursin gene cluster of S. noursei: biosynthesis of dike-
topiperazine metabolites independent of nonribosomal pep-
tide synthetases,” Chemistry and Biology, vol. 9, no. 12, pp.
1355–1364, 2002.
[9] L. Mellouli, R. Ben Ameur-Mehdi, S. Sioud, M. Salem, and
S. Bejar, “Isolation, puriﬁcation and partial characterization
of antibacterial activities produced by a newly isolated Strep-
tomyces sp. US24 strain,” Research in Microbiology, vol. 154,
no. 5, pp. 345–352, 2003.
[10] R.BenAmeur-Mehdi,L.Mellouli,F.Chabchoub,S.Fotso,and
S. Bejar, “Puriﬁcation and structure elucidation of two bio-
logically active molecules from a new isolated Streptomyces sp.
US24 strain,” Chemistry of Natural Compounds,v o l .4 0 ,n o .5 ,
pp. 510–513, 2004.
[11] M. Bierman, R. Logan, K. O’Brien, E. T. Seno, R. N. Rao, and
B. E. Schoner, “Plasmid cloning vectors for the conjugal trans-
fer of DNA from Escherichia coli to Streptomyces spp,” Gene,
vol. 116, no. 1, pp. 43–49, 1992.
[12] J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning:
A Laboratory Manual, Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, USA, 2nd edition, 1989.
[13] E. Stegmann, S. Pelzer, K. Wilken, and W. Wohlleben, “De-
velopment of three diﬀerent gene cloning systems for ge-
netic investigation of the new species Amycolatopsis japonicum
MG417-CF17, the ethylenediaminedisuccinic acid producer,”
Journal of Biotechnology, vol. 92, no. 2, pp. 195–204, 2001.
[ 1 4 ]C .J .T h o m p s o n ,J .M .W a r d ,a n dD .A .H o p w o o d ,“ D N A
cloning in Streptomyces: resistance genes from antibiotic-
producing species,” Nature, vol. 286, no. 5772, pp. 525–527,
1980.
[15] D. Hanahan, “Studies on transformation of Escherichia coli
with plasmids,” Journal of Molecular Biology, vol. 166, no. 4,
pp. 557–580, 1983.
[16] D. J. MacNeil, J. L. Occi, K. M. Gewain, et al., “Complex or-
ganization of the Streptomyces avermitilis genes encoding the
avermectin polyketide synthase,” Gene, vol. 115, no. 1-2, pp.
119–125, 1992.Samiha Sioud et al. 9
[17] M. S. B. Paget, L. Chamberlin, A. Atrih, S. J. Foster, and M. J.
Buttner, “Evidence that the extracytoplasmic function sigma
factor σE is required for normal cell wall structure in Strepto-
myces coelicolor A3(2),” Journal of Bacteriology, vol. 181, no. 1,
pp. 204–211, 1999.
[18] R. H. Baltz, “Genetic recombination by protoplast fusion
in Streptomyces,” Developments in Industrial Microbiology,
vol. 21, pp. 43–54, 1980.
[19] F. Flett, V. Mersinias, and C. P. Smith, “High eﬃciency inter-
genericconjugaltransferofplasmidDNAfromEscherichiacoli
tomethylDNA-restrictingstreptomycetes,” FEMSMicrobiology
Letters, vol. 155, no. 2, pp. 223–229, 1997.
[20] S. Kitani, M. J. Bibb, T. Nihira, and Y. Yamada, “Conjugal
transfer of plasmid DNA from Escherichia coli to Streptomyces
lavendulae FRI-5,” Journal of Microbiology and Biotechnology,
vol. 10, no. 4, pp. 535–538, 2000.
[ 2 1 ] D .A .H o p w o o d ,M .J .B i b b ,K .F .C h a t e r ,e ta l . ,Genetic Manip-
ulation of Streptomyces. A Laboratory Manual, The John Innes
Foundation, Norwich, UK, 1985.
[22] T. Maniatis, E. F. Fritsch, and J. Sambrook, Molecular Cloning,
A Laboratory Manual, Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, USA, 1982.
[23] F. Sanger, S. Nicklen, and A. R. Coulson, “DNA sequencing
withchain-terminatinginhibitors,”ProceedingsoftheNational
Academy of Sciences of the United States of America, vol. 74,
no. 12, pp. 5463–5467, 1977.
[24] S. F. Altschul, T. L. Madden, A. A. Schaﬀer, et al., “Gapped
BLAST and PSI-BLAST: a new generation of protein database
search programs,” Nucleic Acids Research, vol. 25, no. 17, pp.
3389–3402, 1997.
[25] H. D. Mootz, D. Schwarzer, and M. A. Marahiel, “Construc-
tion of hybrid peptide synthetases by module and domain fu-
sions,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 97, no. 11, pp. 5848–5853, 2000.
[26] R. Weckermann, R. F¨ urbaß, and M. A. Marahiel, “Com-
plete nucleotide sequence of the tycA gene coding the tyroci-
dine synthetase 1 from Bacillus brevis,” Nucleic Acids Research,
vol. 16, no. 24, pp. 11841–11852, 1988.
[27] V. De Cr´ ecy-Lagard, V. Blanc, P. Gil, et al., “Pristinamycin I
biosynthesis in Streptomyces pristinaespiralis: molecular char-
acterization of the ﬁrst two structural peptide synthetase
genes,” J o u r n a lo fB a c t e r i o l o g y , vol. 179, no. 3, pp. 705–713,
1997.
[28] F. Schauwecker, F. Pfennig, W. Schr¨ oder, and U. Keller,
“Molecular cloning of the actinomycin synthetase gene cluster
from Streptomyces chrysomallus and functional heterologous
expression of the gene encoding actinomycin synthetase II,”
Journal of Bacteriology, vol. 180, no. 9, pp. 2468–2474, 1998.
[29] P. Mazodier, R. Petter, and C. Thompson, “Intergeneric conju-
gationbetweenEscherichiacoliandStreptomycesspecies,”Jour-
nal of Bacteriology, vol. 171, no. 6, pp. 3583–3585, 1989.